Healthcare & Pharma

The global Influenza Vaccines market is valued at US$6,648.0 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.

The global Antisense Oligonucleotide (ASO) Therapeutics market is valued at US$6,099.3 million in 2023 and is projected to grow at a CAGR of 14.5% during the forecast period 2023-2033.

The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is valued at US$15.6 billion in 2023 and is projected to grow at a CAGR of 7.4% during the forecast period 2023-2033.

The global Orphan Drugs market is valued at US$187.6 billion in 2022 and is projected to grow at a CAGR of 11.1% during the forecast period 2023-2033.

The global 3D Cell Culture and 3D Bioprinting market is valued at US$2,277.2 million in 2023 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.

The global Bioreactors market was estimated to be valued at US$9,977.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.

The global In Silico Clinical Trials market is valued at US$3,078.0 million in 2023 and is projected to grow at a CAGR of 8% during the forecast period 2023-2033.

The global Bionic Devices market was valued at US$19.5 billion in 2022 and is projected to grow at a CAGR of 9.5% during the forecast period 2023-2033.

The global Cancer Vaccines market is valued at US$8,069.5 million in 2023 and is projected to grow at a CAGR of 14% during the forecast period 2023-2033.

The global Clinical Trials Support Services market is valued at US$21.9 billion in 2023 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.

The global Ophthalmic Devices market is projected to grow at a CAGR of 4.6% by 2033

The global Ophthalmic Drugs Contract Manufacturing market was valued at US$3,860.1 million in 2023 and is projected to grow at a CAGR of 6.4% during the forecast period 2023-2033.

Active Pharmaceutical Ingredients (APIs) market was valued at US$ 222 billion in 2022 and is projected to grow at a CAGR of 6.7% during the forecast period 2023-2033.

The global NASH Treatment & Therapeutics market is valued at US$4,657.7 million in 2023 and is projected to grow at a CAGR of 38.6% during the forecast period 2023-2033.